HLA-DRB1 and alkaline phosphatase measurement: In a subsequent prospective screening study at the same centers, avoiding AZA in carriers of the HLA-DQA1–HLA-DRB1*07:01 A>C variant reduced AZA-AP prevalence from 3.4% to 0.3% [14].